BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

Relmada Therapeutics Inc. – Ownership Summary

NASDAQ: RLMD    
Share price (7/6/26): $6.33    
Market cap (7/6/26): $664 million